Search
Searching Content indexed under Healthcare by Norton Rose Fulbright Canada LLP ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7  
>>Next
 
Title
Country
Organisation
Author
Date
1
Competition Bureau Issues Statement Regarding Off-Label Use Of Vaccines
The Competition Bureau recently conducted a preliminary investigation into possible competition concerns arising from a proposal to include a clause in a procurement contract that would restrict off-label use of a vaccine.
Canada
31 Jul 2019
2
Health Canada Consulting On Clinical Trial Requirements And "New Class" Of Advanced Therapeutic Products
As we reported, the Budget Implementation Act, 2019 paved the way for changes to the regulation of clinical trials and created a new class of "advanced therapeutic products" regulated by Health Canada.
Canada
26 Jul 2019
3
Health Canada Consulting On Draft Guidance Distinguishing Promotional And Non-Promotional Activities For Health Products
Health Canada is consulting on a draft guidance document entitled The Distinction Between Promotional and Non-promotional Messages and Activities for Health Products (Draft Guidance), which is intended to replace ...
Canada
24 Jul 2019
4
Health Canada Proposes Updates Relating To Sale Of Unapproved Drugs For Emergency Treatment
Amendments have been proposed to the Food and Drug Regulations that relate to the sale of drugs that have not been approved in Canada for emergency treatment.
Canada
10 Jun 2019
5
Health Canada Changes Cannabis Licensing Process
On the market side, private cannabis companies are driving up cannabis M&A activities.
Canada
23 May 2019
6
Cannabis Law Update – Health Canada Prioritizing Applicants With Fully Built Facilities
On May 8, Health Canada announced that, effective immediately, all new applicants for a licence to cultivate, process, or sell cannabis for medical purposes are required to have a fully built site that meets...
Canada
21 May 2019
7
La santé à l'ère numérique : opportunités et écueils
Notre groupe organise une conférence bien spéciale le 22 mai prochain sur les conséquences de l'intersection entre la santé et l'intelligence artificielle
Canada
21 May 2019
8
Federal Court Of Appeal Affirms Cancellation Of Reconsideration Of ANDS For Apo-Omeprazole
The Federal Court dismissed Apotex's application for judicial review of the Minister's decision to cancel the reconsideration process.
Canada
7 May 2019
9
Proposed Amendments To Food And Drugs Act Introduced In Omnibus Budget Bill
These changes are included in an omnibus budget bill, the Budget Implementation Act, 2019, No 1.
Canada
25 Apr 2019
10
Building The Health Systems Of Tomorrow: Dealmaking And The Future Of The Life Sciences Sector
A major recurrent theme is the ongoing transformation of the industry.
Canada
25 Apr 2019
11
Regulatory Changes For Generics Proposed To Clarify ANDS Pathway Eligibility
The regulations will come into force 90 days after they are registered.
Canada
4 Apr 2019
13
Budget 2019: Federal Government Announces Intention To Implement Recommendations On National Pharmacare
Yesterday, the federal government announced funding to implement this recommendation.
Canada
22 Mar 2019
14
Cannabis Law Update – Voluntary Recall Guide For Licensed Producers
The expected timelines depend on the severity of the reason for the recall.
Canada
15 Mar 2019
15
Ontario Introduces Changes To Healthcare Administration
Bill 74 was introduced in the Ontario legislature on February 26, 2019, and passed first reading.
Canada
14 Mar 2019
16
Ontario Introduces Legislation To Change Healthcare Administration
This week the Ontario government announced legislation that will overhaul the administration of healthcare delivery in Ontario.
Canada
11 Mar 2019
17
Health Canada Rejects Product-Specific Suffixes For Biosimilars In Favour Of Unique Brand Names
Health Canada has decided that all biologic drugs, including biosimilars, will be identified by both their unique brand name and non-proprietary (common) name ...
Canada
4 Mar 2019
18
FCA Confirms Entirety Of Inventors' Conduct Is Relevant In Obviousness Analysis And Upholds Inventiveness Of Crystal Form Patent
The Federal Court of Appeal upheld the validity of Canadian Patent 2,436,668 which covers Form I ODV succinate (marketed as PRISTIQ) in two separate appeals by Apotex Inc. and Teva Canada Ltd, finding that the claims were novel and inventive.
Canada
21 Feb 2019
19
Quebec Court Of Appeal Overturns Minister's Decision To Remove Remicade From Quebec's List Of Medications
The Quebec Court of Appeal has declared a decision by the Minister of Health and Social Services to "delist" Remicade from Quebec's List of Medications to be invalid and has ordered the minister to reinstate the drug...
Canada
15 Feb 2019
20
Health Canada Consulting On The Contents Of The Generic Submissions Under Review List
On January 7, 2019, Health Canada opened a consultation on whether to include the names of sponsor companies on the generic submissions under review list (GSUR) ...
Canada
31 Jan 2019
Links to Result pages
 
1 2 3 4 5 6 7  
>>Next